The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of high-dose methotrexate serum concentration requirement for discharge.
 
Amulya Yellala
No Relationships to Disclose
 
Prajwal Dhakal
No Relationships to Disclose
 
Brooke Deason
No Relationships to Disclose
 
Susanne Liewer
No Relationships to Disclose
 
Avyakta Kallam
No Relationships to Disclose
 
Matthew Alexander Lunning
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen Oncology; Juno Therapeutics; Kite, a Gilead company; Novartis; Pharmacyclics; Seagen; Spectrum Pharmaceuticals; TG Therapeutics; Verastem
Research Funding - Celgene (Inst); Celgene (Inst); Celgene (Inst); Curis (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Juno Therapeutics (Inst); miRagen (Inst); TG Therapeutics (Inst); TG Therapeutics (Inst)
 
Philip Jay Bierman
No Relationships to Disclose
 
Julie Vose
Honoraria - Abbvie; Acerta Pharma/AstraZeneca; Epizyme; Janssen Scientific Affairs; Kite/Gilead; Legend Biotech; Miltenyi Biotec; Novartis; Vaniam Group; Verastem
Consulting or Advisory Role - Bio Connections
Research Funding - Acerta Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); Novartis (Inst); Seagen (Inst)
 
Gregory Bociek
Employment - Innate Pharma
Consulting or Advisory Role - Celgene; Innate Pharma